May 29, 2020 (Market Insight Reports) -- Aspiration and biopsy needles market witnessing a 7.2% CAGR during 2020-2030 (forecast period), the industry revenue is expected surge from $801.5 million in 2019 to $1,717.9 million by 2030, according to the latest research study published by P&S Intelligence , the study covers detailed analysis of aspiration and biopsy needles industry.
Hospitals are expected to be the largest end users in the aspiration and biopsy needles market till 2030. Such establishments employ skilled and highly trained healthcare professionals and have more facilities, which is why patients prefer them over diagnostic centers and clinics.
Request to view sample of this market research: https://www.psmarketresearch.com/market-analysis/aspiration-and-biopsy-needles-market/report-sample
Core needle held the larger revenue share in 2019, as this type of biopsy makes the differentiation between invasive and in situ breast cancer easier. Additionally, the identification of harmless lesions also becomes more efficient with core-needle biopsies.
The objective of this research includes;
To identify recent trends and evolving opportunities for the aspiration and biopsy needles market participants
To evaluate the historical and the present size of the categories under market segmentation and understand their comparative future potential
To estimate the potential of aspiration and biopsy needles industry, so the market players make informed decisions on the production and sale of their products
To study about the major players operating in the aspiration and biopsy needles market and their product offerings
To gain knowledge on recent strategic developments by the major players in the market
Geographically, the highest usage of aspiration and biopsy needles was observed in North America in 2019, mainly due to the rising awareness in the region about the early cancer diagnosis processes, soaring healthcare spending, and surging number of devices being granted approval by the USFDA. The fastest growth in the adoption of aspiration and biopsy needles is expected to be witnessed in the Asia-Pacific (APAC) region during the forecast period. This is primarily ascribed to the increasing pool of cancer patients and rising awareness regarding the various cancer diagnosis methods available in the region.
The major companies operating in the global aspiration and biopsy needles market are Olympus Corporation, Stryker Corporation, Boston Scientific Corporation, Argon Medical Devices Inc., Becton, Dickinson and Company, Medtronic plc, CONMED Corporation, Merit Medial System Inc., Sterylab s.r.l., Cook Medical LLC, and Cardinal Health Inc.
The research includes detailed analysis of;